HIPK3 and breast cancer: In summary, this study demonstrated that hsa_circ_0025202 suppressed carcinogenesis and reduced tamoxifen resistance in BC via regulating miR-197-3p/HIPK3 axis, providing an actionable therapeutic strategy in BC patients with chemoresistance.